Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels
Crossref DOI link: https://doi.org/10.1186/s12882-017-0789-x
Published Online: 2017-12-20
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gant, Christina M.
,
Laverman, Gozewijn D.
Vogt, Liffert
Slagman, Maartje C. J.
Heerspink, Hiddo J. L.
Waanders, Femke
Hemmelder, Marc H.
Navis, Gerjan
Funding for this research was provided by:
Merck Sharp and Dohme (MSGP NETH-15-01)
Novartis (CVAL489ANL08)